FRM
ANGO icon

Fox Run Management’s AngioDynamics ANGO Stock Holding History

Fox Run Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$423K Buy
+32,489
New +$370K 0.07% 539
2025
Q2 		– Sell
-15,468
Closed -$145K – 844
2025
Q1 		$145K Buy
+15,468
New +$163K 0.02% 835
2023
Q4 		– Sell
-10,657
Closed -$77.9K – 712
2023
Q3 		$77.9K Sell
10,657
-5,505
-34% -$45.8K 0.02% 643
2023
Q2 		$169K Buy
+16,162
New +$156K 0.05% 601

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fox Run Management's ANGO Position: Q2 2026 in Review

Fox Run Management opened a new position in AngioDynamics (ANGO) in Q2 2026: 32,489 shares worth $423K. The stake represents 0.07% of the portfolio and ranks #539 among its holdings. This is a return to the name: Fox Run Management previously reported a position in ANGO as recently as Q1 2025.

Fox Run Management first reported a position in ANGO in Q2 2023 and has held it in 4 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Fox Run Management held 32,489 shares of AngioDynamics worth $423K as of Q2 2026.
  • AngioDynamics was a new Fox Run Management position in Q2 2026.
  • AngioDynamics made up 0.07% of Fox Run Management's portfolio in Q2 2026, its #539 holding.
  • Fox Run Management first reported a position in AngioDynamics in Q2 2023 and has held it in 4 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.